Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
NCT03230058Phase 3Unknown
- Sponsor
- L V Prasad Eye Institute
- Start
- Jan 2017
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fungal keratitis (FK) comparing Natamycin + Voriconazole with Natamycin + Placebo (2 arms). Primary endpoint: Complete resolution of the infiltrate with formation of a scar on medical treatment alone at 8 weeks. Status: unknown.
02
Drugs
voriconazole
03
Conditions
fungal keratitis (FK)
Beyond the preview
Go deeper on NCT03230058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230058.